Chronic Therapies For “Unmet Needs” Eligible For 15 Years Exclusivity In House Bill
This article was originally published in The Pink Sheet Daily
Executive Summary
Sponsored by Rep. Lance, R-N.J., the bill also offers data exclusivity incentives aimed at encouraging biopharma companies to co-develop drugs and companion diagnostics for chronic disease.